Gallen consensus meeting of 2015, they showed that hormone receptor-positive/HER2-negative breast cancer may be divided into the luminal A-like type (high ER/PgR and clearly low Ki67), luminal-B like type (low ER/PgR and clearly high Ki67), and intermediate type. The gene discussed is ERBB2; the disease is breast cancer.